Douglas Lane & Associates’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57M Buy
363,648
+58,096
+19% +$10.2M 0.77% 51
2026
Q1
$57M Buy
305,552
+29,421
+11% +$6.1M 0.82% 47
2025
Q4
$73.1M Buy
276,131
+23,403
+9% +$5.82M 1% 31
2025
Q3
$59.9M Buy
252,728
+51,139
+25% +$12.9M 0.83% 44
2025
Q2
$55M Buy
201,589
+52,956
+36% +$14.2M 0.8% 47
2025
Q1
$39.9M Buy
148,633
+5,892
+4% +$1.83M 0.59% 69
2024
Q4
$47.7M Buy
142,741
+52,104
+57% +$16.6M 0.67% 56
2024
Q3
$24.8M Buy
+90,637
New +$23.2M 0.34% 95
2022
Q2
Sell
-1,021
Closed -$217K 217
2022
Q1
$217K Sell
1,021
-44
-4% -$9.47K ﹤0.01% 218
2021
Q4
$271K Buy
1,065
+150
+16% +$42.1K ﹤0.01% 210
2021
Q3
$248K Buy
915
+84
+10% +$21.3K ﹤0.01% 207
2021
Q2
$203K Buy
+831
New +$192K ﹤0.01% 223
2020
Q4
Sell
-856
Closed -$215K 216
2020
Q3
$215K Buy
+856
New +$187K ﹤0.01% 192

Other funds holding CRM

Douglas Lane & Associates's CRM Position: Q2 2026 in Review

Douglas Lane & Associates increased its Salesforce (CRM) stake by 19% in Q2 2026, buying an estimated $10.2M and bringing the position to 363,648 shares worth $57M. The position accounts for 0.77% of the portfolio, ranked #51.

Douglas Lane & Associates first reported a position in CRM in Q3 2020 and has held it in 13 quarters since. The position peaked at $73.1M in Q4 2025. 2,480 funds tracked by Wall St. Rank hold CRM as of Q2 2026.

  • Douglas Lane & Associates held 363,648 shares of Salesforce worth $57M as of Q2 2026.
  • Douglas Lane & Associates bought 58,096 Salesforce shares in Q2 2026, an estimated $10.2M.
  • Salesforce made up 0.77% of Douglas Lane & Associates's portfolio in Q2 2026, its #51 holding.
  • Douglas Lane & Associates first reported a position in Salesforce in Q3 2020 and has held it in 13 quarters since.
  • Douglas Lane & Associates's Salesforce position peaked at $73.1M in Q4 2025.
  • 2,480 funds tracked by Wall St. Rank held Salesforce as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.